Lilly, Novo dominance to continue as TD Cowen lifts GLP-1 sales forecast for 2030 by 38%

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.